# Safety and Tolerability of STP206 in Healthy Adult Subjects

> **NCT00922324** · PHASE1 · COMPLETED · sponsor: **Leadiant Biosciences, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** STP206 or vehicle control

## Key facts

- **NCT ID:** NCT00922324
- **Lead sponsor:** Leadiant Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-06
- **Final completion:** 2010-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00922324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00922324, "Safety and Tolerability of STP206 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00922324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*